|
|
 |
|
Viewing report
|
|
|
|
Protein Drugs - Global Strategic Business Report
Global Industry Analysts, Inc., Aug 2010, Pages: 524
This report analyzes the Global market for Protein Drugs in US$ Million by the following Drug Classes - Antibodies, Blood Products, Cytokines, Peptide Hormones, Vaccines, and Others (Including Peptide Antibiotics and Enzymes). Annual estimates and forecasts are provided for the period 2006 through 2015.
The report profiles 56 companies including many key and niche players such as Abbott Laboratories, Inc., Alexion Pharmaceuticals, Inc., Amgen, Inc., Biogen Idec, Bristol-Myers Squibb Company, Medarex, Inc., Crucell N.V., Dendreon Corporation, Eli Lilly and Company, Emergent BioSolutions, Inc., Genentech, Inc., Johnson & Johnson, Centocor Ortho Biotech, Inc., MedImmune, Inc., Merck Serono S.A., Schering-Plough Corporation, UCB Group, Unigene Laboratories, Inc., and Vaccinogen, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report
Immunochemicals - Global Strategic Business Report
Antibody Partnering Terms and Agreements
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market
Opportunities for Monoclonal Antibodies: Where Companies Are Spending Their Antibody Dollars
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
Drug Delivery in Cancer - Technologies, Markets and Companies
Antibody Technology Companies 2010
Next Generation Protein Engineering and Drug Design: Strategies to boost efficacy and improve drug delivery
|
|
|
|
